A new type of anticoagulant medication and antivitamin A (NOAC) is now recommended as a preferred alternative to warfarin to reduce the risk of AFF, according to a recent update from 2014. American Heart Association / American College of Cardiology / Society Heart Rate Guidelines for the management of patients with atrial fibrillation.
FAib is a type of arrhythmia in the atria or in the upper chambers of the heart. Because the heartbeat is irregular, blood can accumulate and then coagulate in the atria, especially in the left atrium, a pocket that is part of the dissection of the left ventricle of the heart. If the clots formed within the left atrium migrate into the blood and reach the brain, the stroke caused by the obstructed artery can occur even in people who do not have obvious symptoms of AFib.
Anticoagulant medications called anticoagulants have been recommended vexgen keto for a long time to reduce the risk of stroke in patients with AFib who have an increased risk of blood clots (blockage of blood vessels by clotting in the bloodstream) and / or stroke caused by narrowing or blocking arteries
To reduce the risk of stroke in patients with appropriate AFib, a new class of anticoagulant known as NOAC is now the preferred drug category recommended for traditional warfarin, unless the patient has a mild to severe narrowing (narrowing of the valve mitral) or have an artificial heart. . Valve NOACs include dabigatran, rivaroxaban, apixaban and edoxaban.
“Patients with AFib are at risk of stroke, which can be devastating.The goal of treating patients with AFib is to make the blood less likely to form clots, which reduces the risk of stroke. Scientists show that NOACs can be safer for patients “Because the risk of bleeding is lower, it may also be more effective in preventing blood clots than in warfarin,” said Craig T. Jan, MD, co-chair of the Center for Disease Control, published simultaneously at the American Heart Association, College of Cardiology and the Heart Rhythm Society, HeartRhythm.